Cargando…
Clinical Characterization of [(18)F]T-008, a Cholesterol 24-Hydroxylase PET Ligand: Dosimetry, Kinetic Modeling, Variability, and Soticlestat Occupancy
This series of studies characterized [(18)F]T-008, a PET radiotracer for imaging cholesterol 24-hydroxylase (CH24H), in healthy volunteers (ClinicalTrials.gov identifier NCT02497235). Assessments included radiation dosimetry, kinetic modeling, test–retest variability (TRT) evaluation, and a dose occ...
Autores principales: | Constantinescu, Cristian C., Brown, Terry, Wang, Shining, Yin, Wei, Barret, Olivier, Jennings, Danna, Tauscher, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Nuclear Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690114/ https://www.ncbi.nlm.nih.gov/pubmed/37770111 http://dx.doi.org/10.2967/jnumed.123.265912 |
Ejemplares similares
-
Anticonvulsive properties of soticlestat, a novel cholesterol 24‐hydroxylase inhibitor
por: Nishi, Toshiya, et al.
Publicado: (2022) -
Preclinical characterization of [(18)F]T-008, a novel PET imaging radioligand for cholesterol 24-hydroxylase
por: Koike, Tatsuki, et al.
Publicado: (2021) -
Population pharmacokinetics, enzyme occupancy, and 24S‐hydroxycholesterol modeling of soticlestat, a novel cholesterol 24‐hydroxylase inhibitor, in healthy adults
por: Yin, Wei, et al.
Publicado: (2023) -
Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice
por: Nishi, Toshiya, et al.
Publicado: (2020) -
Soticlestat, a novel cholesterol 24‐hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice
por: Hawkins, Nicole A., et al.
Publicado: (2021)